VolitionRX Aktie
WKN DE: A12B6K / ISIN: US9286611077
20.03.2024 03:01:43
|
VolitionRx Names Andrew Retter Chief Medical Officer
(RTTNews) - VolitionRx Limited (VNRX) said it has appointed Andrew Retter as its Chief Medical Officer, effective April 1, 2024.
Andrew is an Intensive Care Consultant at Guy's and St. Thomas' NHS Foundation Trust in London, where he has worked as a Consultant since 2014 and leads Clinical Governance in Critical Care. He specializes in the management of severe respiratory failure, ECMO and thrombosis.
Retter has worked with Volition in an advisory capacity since January 2022.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu VolitionRX Ltdmehr Nachrichten
15.05.25 |
Ausblick: VolitionRX stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) |
Analysen zu VolitionRX Ltdmehr Analysen
Aktien in diesem Artikel
VolitionRX Ltd | 0,63 | 0,99% |
|